LNTH — Lantheus Holdings Share News
0.000.00%
Last trade - 00:00- $7.15bn
- $7.22bn
- $1.54bn
Brief: Lantheus Acquires Global Rights To Life Molecular Imaging’S Novel Therapeutic And Diagnostic Pair
Australia's Radiopharm Theranostics jumps on getting strategic investment
Lantheus Holdings Inc reports results for the quarter ended in March - Earnings Summary
Brief: Lantheus Holdings Q1 Adjusted EPS USD 1.69 Vs. IBES Estimate USD 1.54
Lantheus Holdings Inc expected to post earnings of $1.54 a share - Earnings Preview
U.S. RESEARCH ROUNDUP- Builders Firstsource, Eli Lilly, Northern Trust
Truist bets on a 'beat & raise' Q1 for some med-tech players
Brief: Lantheus Announces US FDA Approval Of DEFINITY For Pediatric Patients
Lantheus Holdings Inc reports results for the quarter ended in December - Earnings Summary
U.S. STOCKS ON THE MOVE-J.B. Hunt, Synopsys, DoorDash
U.S. STOCKS ON THE MOVE-Wayfair Inc, Remitly Global, Monopar Therapeutics
U.S. STOCKS ON THE MOVE-Coty, Planet Fitness, Quanta Services
Lantheus Holdings rises on Q4 results beat
Brief: Lantheus Holdings Q4 Free Cash Flow USD 100.2 Million
Lantheus Holdings Inc expected to post earnings of $1.45 a share - Earnings Preview
Brief: Lantheus Holdings says Confirmed Co, Unit Were Sued By Advanced Accelerator Applications Usa, Advanced Accelerator Applications SA, Each A Novartis Entity
Lantheus Holdings announces CEO succession plan; shares fall
U.S. RESEARCH ROUNDUP-Boeing, Moody's, S&P Global
U.S. RESEARCH ROUNDUP-Array Technologies, Autodesk, Nike